Akesis Pharmaceuticals (AKES) 10-Q 2006 Q2 Quarterly report

Exhibit 32.1

CERTIFICATION

I, Edward B. Wilson, President and Chief Executive Officer of Akesis Pharmaceuticals, Inc. (the “Company”) and I, John T. Hendrick, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2006 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Edward B. Wilson

Edward B. Wilson

President and Chief Executive Officer

/s/ John T. Hendrick

John T. Hendrick

Chief Financial Officer

August 8, 2006

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.